Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
2019 · New England Journal of Medicine · 2,229 citations
https://doi.org/10.1056/nejmoa1908655
M
Michele Senni
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
8.0K
Citations
11
h-index
12
i10-index
Michele Senni is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Heart Failure Treatment and Management & Cardiovascular Function and Risk Factors & Hormonal Regulation and Hypertension. The author has an h-index of 11, co-authored 43 publications.
Papers by this author
worksNT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction
2020 · JACC Heart Failure · 33 citations
https://doi.org/10.1016/j.jchf.2020.05.012
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction
2020 · JACC Heart Failure · 33 citations
https://doi.org/10.1016/j.jchf.2020.05.012
Estimated Long-Term Benefits of Finerenone in Heart Failure
2024 · JAMA Cardiology · 8 citations
https://doi.org/10.1001/jamacardio.2024.3782
Early Initiation of Sacubitril/Valsartan in Patients With Acute Heart Failure and Renal Dysfunction: An Analysis of the TRANSITION Study
2023 · Journal of Cardiac Failure · 7 citations
https://doi.org/10.1016/j.cardfail.2023.08.021
Finerenone, Chronic Obstructive Pulmonary Disease, and Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial
2025 · European Journal of Heart Failure · 7 citations
https://doi.org/10.1002/ejhf.3661
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat